Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency

International Journal of Obesity

Volumn 25, Issue 8, 2001, Pages 1233-1239

  Maccario, M ^a   Aimaretti, G ^a   Grottoli, S ^a   Gauna, C ^a   Tassone, F ^a   Corneli, G ^a   Rossetto, R ^a   Wu, Z ^b   Strasburger, C J ^b   Ghigo, E ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

ALS; Fasting; FFA; GH; GH deficiency; GHBP; IGF I; IGFBP 1; IGFBP 3

Indexed keywords

FATTY ACID; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC RESTRICTION; CLINICAL ARTICLE; DIET RESTRICTION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; HYPOPITUITARISM; INSULIN RELEASE; MALE; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL; PROVOCATION TEST; STARVATION;

ADOLESCENT; ADULT; BLOOD GLUCOSE; FASTING; FEMALE; GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OBESITY; TIME FACTORS;

EID: 0034896661     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801671     Document Type: Article

References (40)

1. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man
2. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: Evidence for a marked somatotroph secretory capability in obesity
3. Maximal secretory capacity of somatotrope cells in obesity: Comparison with GH deficiency
4. Impaired growth hormone secretion in spontaneous experimental obesity: A result of increased somatostatin (SRIF) tone
5. Sex-related alterations in hypothalamic growth hormone-releasing hormone mRNA-but not somatostatin mRNA-expressing cells in genetically obese Zucker rats
6. Obesity-associated decrease in growth hormone-releasing hormone gene expression: A mechanism for reduced growth hormone mRNA levels in genetically obese Zucker rats
7. Free insulin-like growth factors in human obesity
8. Insulin suppresses growth hormone secretion by rat pituitary cells
9. Regulation of in vivo growth hormone secretion by leptin
10. Effects of acipimox, an antilipolyric drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity
11. Regulation of somatotroph cell function by the adipose tissue
12. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man
13. Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men
14. Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes
15. The GH/IGF-I axis in obesity: Influence of neuro-endocrine and metabolic factors
16. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects
17. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects
18. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine
19. The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults
20. Ligand-mediated immunofunctional assay for quantitation of growth hormone-binding protein in human blood
21. A non isotopic solid phase immunoassay for the determination of growth hormone binding protein (hGHBP)
22. Activation of chimeric and full-length growth hormone receptors by growth hormone receptor monoclonal antibodies. A specific conformational change may be required for full-length receptor signaling
23. Pulsatile growth hormone secretion in normal-weight and obese men: Differential metabolic regulation during energy restriction
24. Reduction of plasma immunoreactive somatomedin C during fasting in humans
25. Liver-derived insulin-like growth factor-I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
26. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (GH) response to GH-releasing hormone in obesity
27. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans
28. Diagnosis of growth-hormone deficiency in adults
29. Long-term administration of acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid in obesity
30. Suppression of counter-regulatory hormone response to hypoglycemia by insulin per se
31. Interaction between body composition, leptin and growth hormone status
32. Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat
33. Insulin regulation of insulin-like growth factor binding protein-I in obese and nonobese humans
34. Effect of insulin on rat anterior pituitary cells
35. Leptin production during early starvation in lean and obese women
36. Effects of free fatty acids on somatostatin secretion, content and mRNA levels in cortical and hypothalamic fetal rat neurones in monolayer culture
37. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism
38. Effect of short-term fasting on lipid kinetics in lean and obese women
39. Changes in the circulating IGF system during short-term fasting and refeeding in rats
40. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects